Literature DB >> 15192044

Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis.

Christophe Perrin1, Claude Knauf, Rémy Burcelin.   

Abstract

The AMP-activated kinase has been proposed to be an important intracellular energy sensor because the enzyme controls lipid and glucose oxidation. In the corresponding knockout mice, insulin-stimulated muscle glycogen synthesis and glucose tolerance are reduced. In addition, these mice excrete catecholamines in excess, suggesting that the central and autonomic nervous systems are impaired. Indeed, in the brain, fuel sensor mechanisms have been described, and recently, evidence has shown that the AMP-activated kinase could control food intake. We show in this study that the intracerebroventricular infusion of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR), a pharmacological AMP-activated kinase activator, increased insulin-stimulated muscle glycogen synthesis and insulin sensitivity during a hyperinsulinemic clamp. Similarly, we infused AICAR in the brain of fasted mice, i.e. when insulinemia was low, and showed that muscle glycogen synthesis was also increased. We then studied the effect of a cerebral infusion of the peripheral signals, i.e. insulin and glucose, known to be detected by the brain. The cerebral infusion of insulin increased muscle glycogen synthesis. This effect was blunted by the coinfusion of glucose, which induced insulin resistance. Importantly, the cerebral injections of AICAR, insulin, and glucose were associated with variations in the phosphorylation state of the AMP-activated kinase in the hypothalamus. In conclusion, our data showed for the first time that 1) the brain is sensitive to insulin and glucose for the regulation of muscle glycogen synthesis; and 2) the cerebral infusion of AICAR enhances insulin sensitivity. Although the above mechanisms are correlated with the regulation of AMP-activated kinase, the direct involvement of the enzyme in the mechanism remains to be demonstrated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15192044     DOI: 10.1210/en.2004-0270

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  28 in total

Review 1.  Role of hypothalamic 5'-AMP-activated protein kinase in the regulation of food intake and energy homeostasis.

Authors:  Min Seon Kim; Ki Up Lee
Journal:  J Mol Med (Berl)       Date:  2005-04-02       Impact factor: 4.599

2.  Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.

Authors:  Claude Knauf; Patrice D Cani; Christophe Perrin; Miguel A Iglesias; Jean François Maury; Elodie Bernard; Fadilha Benhamed; Thierry Grémeaux; Daniel J Drucker; C Ronald Kahn; Jean Girard; Jean François Tanti; Nathalie M Delzenne; Catherine Postic; Rémy Burcelin
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 3.  Targeting the CNS to treat type 2 diabetes.

Authors:  Darleen A Sandoval; Silvana Obici; Randy J Seeley
Journal:  Nat Rev Drug Discov       Date:  2009-05       Impact factor: 84.694

Review 4.  Regulation of hepatic glucose uptake and storage in vivo.

Authors:  Mary Courtney Moore; Katie C Coate; Jason J Winnick; Zhibo An; Alan D Cherrington
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

Review 5.  Hypothalamic control of energy and glucose metabolism.

Authors:  Stephanie Sisley; Darleen Sandoval
Journal:  Rev Endocr Metab Disord       Date:  2011-09       Impact factor: 6.514

6.  Effect of L-carnitine Supplementation on Nutritional Status and Physical Performance Under Calorie Restriction.

Authors:  Swati Jain; Som Nath Singh
Journal:  Indian J Clin Biochem       Date:  2014-05-04

Review 7.  Central insulin and leptin-mediated autonomic control of glucose homeostasis.

Authors:  Joseph S Marino; Yong Xu; Jennifer W Hill
Journal:  Trends Endocrinol Metab       Date:  2011-04-12       Impact factor: 12.015

8.  Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions.

Authors:  M Heni; S Kullmann; C Ketterer; M Guthoff; K Linder; R Wagner; K T Stingl; R Veit; H Staiger; H-U Häring; H Preissl; A Fritsche
Journal:  Diabetologia       Date:  2012-03-21       Impact factor: 10.122

Review 9.  Role of AMP-activated protein kinase in the control of appetite.

Authors:  B Kola
Journal:  J Neuroendocrinol       Date:  2008-04-28       Impact factor: 3.627

Review 10.  Where does insulin resistance start? The brain.

Authors:  Uberto Pagotto
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.